Get the tools used by (smart)2 investors.

Unadjusted EBIT CAGR (5y) for GSK plc DRC

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

GSK: GSK plc DRC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...

39.24 USD
Price
USD
Fair Value
Upside
31.71 - 45.92
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on GSK plc DRC's Unadjusted EBIT CAGR (5y):

GSKHLTH.GBAZN0QLR0QOK0O59LABB-10.0%0.0%10.0%20.0%30.0%

Performance Summary
  • GSK plc DRC's unadjusted ebit cagr (5y) is -10.4%

How does GSK plc DRC's Unadjusted EBIT CAGR (5y) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to GSK plc DRC because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Unadjusted EBIT CAGR (5y)

Hide this widget
ebit_unadj_cagr_5y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Unadjusted EBIT CAGR (5y) in the growth category include:

View Full List

Search for metric or datapoint

Unadjusted EBIT CAGR (5y)

Five-year compound annual growth rate in unadjusted EBIT.

Definition of Unadjusted EBIT CAGR (5y)

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-28.6%-3.6%21.4%61.9%02040

The chart above depicts the distribution of unadjusted ebit cagr (5y) for companies operating in the Healthcare sector in the Developed economic region. Over 360 companies were considered in this analysis, and 355 had meaningful values. The average unadjusted ebit cagr (5y) of companies in the sector is 5.6% with a standard deviation of 16.0%.

GSK plc DRC's Unadjusted EBIT CAGR (5y) of -10.4% ranks in the 15.1% percentile for the sector. The following table provides additional summary stats:

Unadjusted EBIT CAGR (5y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents369
Included Constituents355
Min-31.5%
Max58.8%
Median5.5%
Mean5.6%
Standard Deviation16.0%

You can find companies with similar unadjusted ebit cagr (5y) using this stock screener.

All rights reserved. Terms Of Use